| 英文名称 | Gracillin |
|---|---|
| 中文名称 | 纤细薯蓣皂苷/纤细皂苷 |
| CAS号 | 19083-00-2 |
| 分子式 | C45H72O17 |
| 分子量 | 885.04 |
| 外观 | |
| 熔点 | 290-293 °C |
| 酸度系数pKa | 12.78±0.70 | Condition: Most Acidic Temp: 25 °C |
| 英文名称 | Gracillin |
|---|---|
| 中文名称 | 纤细薯蓣皂苷/纤细皂苷 |
| CAS号 | 19083-00-2 |
| 分子式 | C45H72O17 |
| 分子量 | 885.04 |
| 外观 | |
| 熔点 | 290-293 °C |
| 酸度系数pKa | 12.78±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000594
中文名称：纤细薯蓣皂苷
中文别名：纤细皂苷
英文名称：Gracillin
英文别名：Gracillin (6CI,7CI,8CI);(3β,25R)-Spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranoside;25(R)-Diosgenin 3-O-β-D-glucopyranosyl-(1→3)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside;Diosgenin 3-O-(α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→3)])-β-D-glucopyranoside;Diosgenin 3-O-β-gracillimatrioside;Dulcamarin C;Gracilline;Lilioglycoside G;NSC 698787;
分子式：C45H72O17
分子量：885.04
CAS号：19083-00-2
纯度：HPLC≥98%
熔点：290-293 °C
密度：1.42±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数：12.78±0.70 | Condition: Most Acidic Temp: 25 °C
储存条件：-20℃，干燥、避光、密封
规格：5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位：四川省维克奇生物科技有限公司
供应电话：028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，化学合成，抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等，敬请关注！ 新批次有现货，欢迎咨询。
| In-situ growth of a spherical vinyl-functionalized covalent organic framework as stationary phase for capillary electrochromatography-mass spectrometry analysis | ||
| 来源：SCI：TALANTA | 作者：Wenqi Sun | 备注：影响因子：6.057 |
| 引用描述 | ||
Evodiamine, rutaecarpine, limonin were purchased from Chengdu herbpurify CO., Ltd (Chengdu, China). Polyphyllin VII, polyphyllin E and gracillin were obtained from Sichuan Weikeqi Biological Technology Co., Ltd (Chengdu, China). Carbamazepine and oxcarbazepine were bought from TCI Chemical Industry Development Co., Ltd (Shanghai, China). | ||
| Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
| 来源：SCI：PHARMACOLOGICAL RESEARCH | 作者：Min Xu | 备注：影响因子：4.816 |
| 引用描述 | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). | ||
